Holding
Gilead Sciences, Inc.GILD
Biopharmaceutical company with $165B market cap and 79% gross margin. Equal-weighted at 5%; HIV and oncology franchises provide predictable cash generation.
weight · 5.00%·sector · Healthcare
SPY+0.17%QQQ+0.03%NVDA+4.01%MSFT+0.05%AAPL−1.27%GOOGL+1.72%META+0.53%AMZN−1.09%TSLA+0.63%AVGO−1.08%SPY+0.17%QQQ+0.03%NVDA+4.01%MSFT+0.05%AAPL−1.27%GOOGL+1.72%META+0.53%AMZN−1.09%TSLA+0.63%AVGO−1.08%